HomeBDRX • NASDAQ
Biodexa Pharmaceuticals PLC-ADR
Follow
In the news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 1.02M | -11.22% |
Net income | -1.65M | 7.29% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -2.08M | 0.38% |
Effective tax rate | 3.64% | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 5.06M | -3.29% |
Total assets | 13.97M | 75.43% |
Total liabilities | 5.24M | 96.81% |
Total equity | 8.73M | — |
Shares outstanding | 362.61K | — |
Price to book | 0.07 | — |
Return on assets | -37.79% | — |
Return on capital | -57.95% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (GBP) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | -1.65M | 7.29% |
Cash from operations | -2.40M | -23.86% |
Cash from investing | -377.00K | -3,870.00% |
Cash from financing | 2.32M | -25.70% |
Net change in cash | -458.00K | -138.31% |
Free cash flow | -1.62M | -28.81% |
Previous close
$1.65
Day range
$1.52 - $1.65
Year range
$1.14 - $74.00
Market cap
1.04M USD
Avg Volume
2.89M
About
Founded
2000
Website
Employees
21
